Putting priming into perspective-from cellular heterogeneity to cellular plasticity

Immunology Today

Volumn 21, Issue 5, 2000, Pages 218-222

  Kroegel, Claus ^a   Foerster, Martin ^a   Häfner, Daniela ^a   Grahmann, P Reinhard ^a   Warner, Jane A ^b   Braun, Ruedi ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; CYTOKINE; FORMYLMETHIONYLPHENYLALANINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 5; LEUKOTRIENE C4; MEMBRANE ANTIGEN; PROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ASTHMATIC STATE; CELL ACTIVATION; CELL DENSITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL HETEROGENEITY; CELL STRUCTURE; CYTOLOGY; EOSINOPHIL; HUMAN; HUMAN CELL; INFLAMMATORY CELL; MACROPHAGE; NORMAL HUMAN; PHENOTYPE; PLASTICITY; PRIORITY JOURNAL; REGULATORY MECHANISM; RESPIRATORY BURST;

EID: 0034018952     PISSN: 01675699     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5699(00)01597-8     Document Type: Note

References (35)

1. Johnston R.B.et al. Priming of macrophages for enhanced oxidative metabolism by exposure to proteolytic enzymes. J. Exp. Med. 153:1981;1678-1683.
2. Miyagawa H.et al. Density distribution and density conversion of neutrophils in allergic subjects. Int. Arch. Allergy Appl. Immunol. 93:1990;8-13.
3. Ochensberger B.et al. Regulation of cytokine expression and leukotriene formation in human basophils by growth factors, chemokines, and chemotactic agonists. Eur. J. Immunol. 29:1999;11-22.
4. Garraud O.et al. Induction of parasite antigen-specific antibody responses in unsensitized human B cells is dependent on the presence of cytokines after T cell priming. J. Immunol. 159:1997;4793-4798.
5. Koenderman L.et al. Eosinophil priming by cytokines, from cellular signal to in vivo modulation. Eur. Respir. J. 9(Suppl. 22):1996;119s-125s.
6. Kroegel C.et al. Eosinophil priming and migration in idiopathic pulmonary fibrosis. Eur. Respir. J. 11:1998;1-3.
7. Kroegel C.et al. Pulmonary immune cells in health and disease. The eosinophil leukocyte. Part I. Eur. Respir. J. 7:1994;519-543.
8. Weller P.F. The immunobiology of eosinophils. New Engl. J. Med. 324:1991;1110-1118.
9. Silberstein D.S.et al. Hemopoietins for eosinophils. Glycoprotein hormones that regulate the development of inflammation in eosinophila-associated disease. Hematol. Oncol. Clin. North Am. 3:1989;511-533.
10. Takafuji S.et al. IL-3 and IL-5 prime normal human eosinophils to produce leukotriene C4 in response to soluble agonists. J. Immunol. 147:1991;3855-3861.
11. Kita H.et al. Release of granule proteins from eosinophils cultured with IL-5. J. Immunol. 146:1992;629-635.
12. Shindo K.et al. Priming effect of platelet activating factor on leukotriene C4 from stimulated eosinophils of asthmatic patients. Thorax. 51:1996;155-158.
13. Chocrane C.G. The enhancement of inflammatory injury. Am. Rev. Respir. Dis. 136:1987;1-2.
14. Anwar A.R.F.et al. Adhesion to fibronectin prolongs eosinophil survival. J. Exp. Med. 177:1993;834-839.
15. Nagata M.et al. Eosinophil adhesion to vascular cell adhesion molecule-1 activates superoxide anion generation. J. Immunol. 155:1995;2194-2202.
16. Liles W.C.et al. Cross-linking of CD18 primes human neutrophils for activation of the respiratory burst in response to specific stimuli, implications for adhesion-dependent physiological responses in neutrophils. J. Leukocyte Biol. 56:1995;690-697.
17. Steeber D.A.et al. Ligation of L-selectin through conservative regions within the lectin domain activates signal transduction pathways and integrin function in human, mouse, and rat leukocytes. J. Immunol. 159:1997;952-963.
18. Dvorak A.M.et al. Megakaryocytes, platelets, macrophages and eosinophils (Vol. 2). 1990;237-344 Plenum.
19. Yukawa T.et al. Density heterogeneity of eosinophil leukocytes, induction of hypodense eosinophils by platelet activating factor. Immunology. 681:1989;40-43.
20. Kroegel C.et al. Ultrastructural characterization of platelet activating factor-stimulated human eosinophils from subjects with asthma. Clin. Sci. 84:1993;391-399.
21. Zeck-Kapp G.et al. Mechanisms of human eosinophil activation by complement protein C5a and platelet activation factor, similar functional responses are accompanied by different morphological alterations. Allergy. 50:1995;34-47.
22. Hansel T.T.et al. Induction and function of eosinophil intercellular adhesion molecule-1 and HLA-DR. J. Immunol. 149:1992;2130-2136.
23. Berends C.et al. Inhibition of PAF-induced expression of CD11b and shedding of L-selectin on human neutrophils and eosinophils by the type IV selective PDE inhibitor, rolipram. Eur. Respir. J. 10:1997;1000-1007.
24. Luttmann W.et al. Activation of human eosinophils by interleukin-13. Induction of CD69 surface antigen, its relationship to messenger RNA expression and promotion of cellular viability. J. Immunol. 157:1996;1678-1683.
25. Kroegel C.et al. Blood and bronchoalveolar eosinophils in allergic subjects after segmental antigen challenge. Surface phenotype, density heterogeneity and prostanoid production. J. Allergy Clin. Immunol. 93:1994;725-734.
26. Sedgwick J.B.et al. Comparison of airway and blood eosinophil function after in vivo antigen challenge. J. Immunol. 149:1992;3710-3718.
27. Prin L.et al. Heterogeneity of human eosinophils. II. Variability of respiratory burst activity related to cell density. Clin. Exp. Immunol. 57:1984;735-742.
28. Shult P.A.et al. The presence of hypodense eosinophils and diminished chemiluminescence response in asthma. J. Allergy Clin. Immunol. 81:1988;429-435.
29. Kauffman H.F.et al. Leukotriene C4 production by normal-density and low-density eosinophils of atopic individuals and other patients with eosinophilia. J. Allergy Clin. Immunol. 79:1987;611-619.
30. Hodges M.K.et al. Heterogeneity of leukotriene C4 production by eosinophils from asthmatic and normal subjects. Am. Rev. Respir. Dis. 138:1988;799-804.
31. Silberstein D.S.et al. Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor. J. Immunol. 137:1986;3290-3294.
32. Daniels R.H.et al. Recombinant human monocyte IL-8 primes NADPH-oxidase and phospholipase A2 activation in human neutrophils. Immunology. 75:1992;157-163.
33. 4 formation in human blood basophils. Blood. 86:1995;4039-4049.
34. Kitchen E.et al. Demonstration of reversible priming of human neutrophils using platelet-activating factor. Blood. 88:1996;4330-4337.
35. Kroegel C.et al. Kummer F. Asthma - Immunopathology und Immunotherapy. 1993;34-54 Springer.